At the time of writing, Medtronic Plc [MDT] stock is trading at $89.39, down -0.41%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MDT shares have gain 1.43% over the last week, with a monthly amount glided 0.06%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Medtronic Plc [NYSE: MDT] stock has seen the most recent analyst activity on August 21, 2024, when Oppenheimer reiterated its Perform rating and also boosted its price target to $94 from $92. Previously, UBS upgraded its rating to Neutral on August 15, 2024, and elevated its price target to $90. On August 14, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $85 on the stock. Goldman started tracking the stock assigning a Sell rating and suggested a price target of $83 on May 30, 2024. Robert W. Baird initiated its recommendation with a Neutral and recommended $90 as its price target on July 19, 2023. CL King started tracking with a Buy rating for this stock on June 30, 2023, and assigned it a price target of $106. In a note dated May 30, 2023, Morgan Stanley upgraded an Overweight rating on this stock but restated the target price of $104.
For the past year, the stock price of Medtronic Plc fluctuated between $68.84 and $91.49. Currently, Wall Street analysts expect the stock to reach $106.77 within the next 12 months. Medtronic Plc [NYSE: MDT] shares were valued at $89.39 at the most recent close of the market. An investor can expect a potential return of 19.44% based on the average MDT price forecast.
Analyzing the MDT fundamentals
According to Medtronic Plc [NYSE:MDT], the company’s sales were 32.58B for trailing twelve months, which represents an 2.77% jump. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.08 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 88.92 points at the first support level, and at 88.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 90.13, and for the 2nd resistance point, it is at 90.87.
Ratios To Look Out For
It is important to note that Medtronic Plc [NYSE:MDT] has a current ratio of 2.13. Also, the Quick Ratio is 1.61, while the Cash Ratio stands at 0.13. Considering the valuation of this stock, the price to sales ratio is 3.52, the price to book ratio is 2.39 and price to earnings (TTM) ratio is 30.07.
Transactions by insiders
Recent insider trading involved PARKHILL KAREN L, Former Officer, that happened on Aug 26 ’24 when 2668.0 shares were purchased. Chairman and CEO, Martha Geoffrey completed a deal on Jun 07 ’24 to sell 19113.0 shares. Meanwhile, EVP & President, Surgical OU Marinaro Michael sold 854.0 shares on Apr 08 ’24.
